Jan 19, 2026 12:00PM
May 7, 2025 01:00AM
Mar 20, 2025 02:00AM
May 31, 2024 11:35AM
Mar 26, 2024 02:00AM
Mar 30, 2023 01:00AM
Mar 23, 2023 02:00AM Valneva Reports Full Year 2022 Results and Provides Corporate Updates
Mar 2, 2023 01:00AM
Feb 20, 2023 01:00AM
Feb 17, 2023 01:00AM
Feb 14, 2023 01:00AM
Dec 30, 2022 12:30PM
Dec 23, 2022 01:00AM
Dec 6, 2022 01:00AM Valneva Hosts Investor Day in New York City
Dec 5, 2022 01:00AM
Dec 1, 2022 01:00AM
Nov 10, 2022 01:00AM
Oct 10, 2022 01:00AM
Sep 26, 2022 01:00AM
Sep 16, 2022 04:30PM
Sep 6, 2022 01:00AM Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
Aug 29, 2022 01:00AM
Aug 23, 2022 11:45AM
Aug 18, 2022 12:00PM
Aug 11, 2022 01:00AM
Aug 8, 2022 04:45PM
Aug 8, 2022 04:45PM
Aug 1, 2022 11:45AM Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine
Jul 20, 2022 12:00PM
Jul 20, 2022 12:00PM
Jun 24, 2022 12:00PM
Jun 24, 2022 12:00PM
Jun 24, 2022 01:05AM
Jun 23, 2022 09:16AM
Jun 20, 2022 01:00AM Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
Jun 20, 2022 01:00AM
Jun 15, 2022 11:46AM
Jun 15, 2022 11:45AM
Jun 10, 2022 12:30PM
Jun 10, 2022 12:30PM
May 25, 2022 01:00AM
May 19, 2022 01:00AM EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate
May 16, 2022 01:15AM
May 16, 2022 01:00AM
May 5, 2022 01:00AM
May 4, 2022 11:45AM
Apr 26, 2022 06:45AM
Apr 26, 2022 01:00AM
Apr 25, 2022 01:00AM Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate
Apr 14, 2022 06:50AM

322,246 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All